{
  "Variants Include": [
    {
      "Gene": "TP53",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Hereditary Myopathy",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Co-immunoprecipitation followed by mass spectrometry",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using the HEK293 cell line."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Mass spectrometry data showed a substantial reduction in the interaction of the TP53 protein with its binding partners in cells expressing the c.248G>A variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed, each with a different clonal cell line derived from the initial HEK293 cell line."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate for mass spectrometry."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type cDNA was expressed as a positive control for TP53-binding partner interaction."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control demonstrating the absence of TP53-binding partner interaction."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Interaction scores greater than 2.0 for TP53-binding partners.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Interaction scores less than 0.5 for TP53-binding partners.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}